Caris Life Sciences, Inc.
Caris Life Sciences, Inc. (CAI) Stock Competitors & Peer Comparison
See (CAI) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CAI | $29.54 | +0.17% | 8.2B | -11.49 | -$2.57 | N/A |
| URI | $890.00 | +1.69% | 57.3B | 23.06 | $38.60 | +0.77% |
| AER | $112.18 | +0.15% | 19.8B | 9.97 | $11.25 | +0.93% |
| CTOS-WT | $0.11 | -7.93% | 18B | N/A | N/A | N/A |
| FTAI | $117.18 | +6.60% | 12B | 488.25 | $0.24 | +1.03% |
| UHAL | $63.23 | +0.02% | 11.2B | 37.46 | $1.69 | N/A |
| UHAL-B | $56.03 | -0.50% | 11.1B | 33.14 | $1.69 | N/A |
| R | $182.60 | +3.09% | 7.5B | 15.53 | $11.76 | +1.78% |
| CAR | $206.79 | -0.37% | 7.3B | -3.31 | -$62.37 | N/A |
| AL | $58.06 | +0.71% | 6.5B | 10.16 | $5.72 | +1.50% |
Stock Comparison
CAI vs URI Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, URI has a market cap of 57.3B. Regarding current trading prices, CAI is priced at $29.54, while URI trades at $890.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas URI's P/E ratio is 23.06. In terms of profitability, CAI's ROE is +0.04%, compared to URI's ROE of +0.29%. Regarding short-term risk, CAI is less volatile compared to URI. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check URI's competition here
CAI vs AER Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, AER has a market cap of 19.8B. Regarding current trading prices, CAI is priced at $29.54, while AER trades at $112.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas AER's P/E ratio is 9.97. In terms of profitability, CAI's ROE is +0.04%, compared to AER's ROE of +0.13%. Regarding short-term risk, CAI is more volatile compared to AER. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check AER's competition here
CAI vs CTOS-WT Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, CTOS-WT has a market cap of 18B. Regarding current trading prices, CAI is priced at $29.54, while CTOS-WT trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas CTOS-WT's P/E ratio is N/A. In terms of profitability, CAI's ROE is +0.04%, compared to CTOS-WT's ROE of -0.02%. Regarding short-term risk, CAI is less volatile compared to CTOS-WT. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check CTOS-WT's competition here
CAI vs FTAI Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, FTAI has a market cap of 12B. Regarding current trading prices, CAI is priced at $29.54, while FTAI trades at $117.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas FTAI's P/E ratio is 488.25. In terms of profitability, CAI's ROE is +0.04%, compared to FTAI's ROE of +0.79%. Regarding short-term risk, CAI is less volatile compared to FTAI. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check FTAI's competition here
CAI vs UHAL Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, UHAL has a market cap of 11.2B. Regarding current trading prices, CAI is priced at $29.54, while UHAL trades at $63.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas UHAL's P/E ratio is 37.46. In terms of profitability, CAI's ROE is +0.04%, compared to UHAL's ROE of +0.05%. Regarding short-term risk, CAI is more volatile compared to UHAL. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check UHAL's competition here
CAI vs UHAL-B Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, UHAL-B has a market cap of 11.1B. Regarding current trading prices, CAI is priced at $29.54, while UHAL-B trades at $56.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas UHAL-B's P/E ratio is 33.14. In terms of profitability, CAI's ROE is +0.04%, compared to UHAL-B's ROE of +0.05%. Regarding short-term risk, CAI is more volatile compared to UHAL-B. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check UHAL-B's competition here
CAI vs R Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, R has a market cap of 7.5B. Regarding current trading prices, CAI is priced at $29.54, while R trades at $182.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas R's P/E ratio is 15.53. In terms of profitability, CAI's ROE is +0.04%, compared to R's ROE of +0.17%. Regarding short-term risk, CAI is less volatile compared to R. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check R's competition here
CAI vs CAR Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, CAR has a market cap of 7.3B. Regarding current trading prices, CAI is priced at $29.54, while CAR trades at $206.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas CAR's P/E ratio is -3.31. In terms of profitability, CAI's ROE is +0.04%, compared to CAR's ROE of +1.51%. Regarding short-term risk, CAI is less volatile compared to CAR. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check CAR's competition here
CAI vs AL Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, AL has a market cap of 6.5B. Regarding current trading prices, CAI is priced at $29.54, while AL trades at $58.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas AL's P/E ratio is 10.16. In terms of profitability, CAI's ROE is +0.04%, compared to AL's ROE of +0.09%. Regarding short-term risk, CAI is more volatile compared to AL. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check AL's competition here
CAI vs AL-PA Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, AL-PA has a market cap of 5.9B. Regarding current trading prices, CAI is priced at $29.54, while AL-PA trades at $35.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas AL-PA's P/E ratio is -26.35. In terms of profitability, CAI's ROE is +0.04%, compared to AL-PA's ROE of +0.09%. Regarding short-term risk, CAI is more volatile compared to AL-PA. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check AL-PA's competition here
CAI vs WSC Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, WSC has a market cap of 5.8B. Regarding current trading prices, CAI is priced at $29.54, while WSC trades at $31.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas WSC's P/E ratio is 395.63. In terms of profitability, CAI's ROE is +0.04%, compared to WSC's ROE of +0.01%. Regarding short-term risk, CAI is more volatile compared to WSC. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check WSC's competition here
CAI vs PONY Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, PONY has a market cap of 5.5B. Regarding current trading prices, CAI is priced at $29.54, while PONY trades at $15.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas PONY's P/E ratio is -17.80. In terms of profitability, CAI's ROE is +0.04%, compared to PONY's ROE of -0.42%. Regarding short-term risk, CAI is less volatile compared to PONY. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check PONY's competition here
CAI vs GATX Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, GATX has a market cap of 5.5B. Regarding current trading prices, CAI is priced at $29.54, while GATX trades at $153.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas GATX's P/E ratio is 19.43. In terms of profitability, CAI's ROE is +0.04%, compared to GATX's ROE of +0.12%. Regarding short-term risk, CAI is more volatile compared to GATX. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check GATX's competition here
CAI vs HRI Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, HRI has a market cap of 5B. Regarding current trading prices, CAI is priced at $29.54, while HRI trades at $149.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas HRI's P/E ratio is 33.30. In terms of profitability, CAI's ROE is +0.04%, compared to HRI's ROE of +0.09%. Regarding short-term risk, CAI is more volatile compared to HRI. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check HRI's competition here
CAI vs TRTN Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, TRTN has a market cap of 4.4B. Regarding current trading prices, CAI is priced at $29.54, while TRTN trades at $79.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas TRTN's P/E ratio is 7.74. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN's ROE of +0.20%. Regarding short-term risk, CAI is less volatile compared to TRTN. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check TRTN's competition here
CAI vs HEES Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, HEES has a market cap of 3.5B. Regarding current trading prices, CAI is priced at $29.54, while HEES trades at $94.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas HEES's P/E ratio is 38.01. In terms of profitability, CAI's ROE is +0.04%, compared to HEES's ROE of +0.14%. Regarding short-term risk, CAI is more volatile compared to HEES. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check HEES's competition here
CAI vs MGRC Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, MGRC has a market cap of 3.1B. Regarding current trading prices, CAI is priced at $29.54, while MGRC trades at $124.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas MGRC's P/E ratio is 12.12. In terms of profitability, CAI's ROE is +0.04%, compared to MGRC's ROE of +0.22%. Regarding short-term risk, CAI is less volatile compared to MGRC. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check MGRC's competition here
CAI vs FTAIM Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, FTAIM has a market cap of 2.7B. Regarding current trading prices, CAI is priced at $29.54, while FTAIM trades at $26.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas FTAIM's P/E ratio is N/A. In terms of profitability, CAI's ROE is +0.04%, compared to FTAIM's ROE of +0.79%. Regarding short-term risk, CAI is more volatile compared to FTAIM. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAIM's competition here
CAI vs TRTN-PA Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, TRTN-PA has a market cap of 2.6B. Regarding current trading prices, CAI is priced at $29.54, while TRTN-PA trades at $26.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas TRTN-PA's P/E ratio is 3.24. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN-PA's ROE of +0.20%. Regarding short-term risk, CAI is more volatile compared to TRTN-PA. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TRTN-PA's competition here
CAI vs FTAIN Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, FTAIN has a market cap of 2.6B. Regarding current trading prices, CAI is priced at $29.54, while FTAIN trades at $25.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas FTAIN's P/E ratio is -7.36. In terms of profitability, CAI's ROE is +0.04%, compared to FTAIN's ROE of +0.79%. Regarding short-term risk, CAI is more volatile compared to FTAIN. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAIN's competition here
CAI vs FTAIO Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, FTAIO has a market cap of 2.6B. Regarding current trading prices, CAI is priced at $29.54, while FTAIO trades at $25.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas FTAIO's P/E ratio is -7.34. In terms of profitability, CAI's ROE is +0.04%, compared to FTAIO's ROE of +0.79%. Regarding short-term risk, CAI is more volatile compared to FTAIO. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAIO's competition here
CAI vs FTAIP Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, FTAIP has a market cap of 2.6B. Regarding current trading prices, CAI is priced at $29.54, while FTAIP trades at $25.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas FTAIP's P/E ratio is -7.32. In terms of profitability, CAI's ROE is +0.04%, compared to FTAIP's ROE of +0.79%. Regarding short-term risk, CAI is more volatile compared to FTAIP. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAIP's competition here
CAI vs TRTN-PB Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, TRTN-PB has a market cap of 2.6B. Regarding current trading prices, CAI is priced at $29.54, while TRTN-PB trades at $25.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas TRTN-PB's P/E ratio is 3.14. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN-PB's ROE of +0.20%. Regarding short-term risk, CAI is more volatile compared to TRTN-PB. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TRTN-PB's competition here
CAI vs TRTN-PC Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, TRTN-PC has a market cap of 2.5B. Regarding current trading prices, CAI is priced at $29.54, while TRTN-PC trades at $24.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas TRTN-PC's P/E ratio is 3.04. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN-PC's ROE of +0.20%. Regarding short-term risk, CAI is more volatile compared to TRTN-PC. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TRTN-PC's competition here
CAI vs TRTN-PD Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, TRTN-PD has a market cap of 2.3B. Regarding current trading prices, CAI is priced at $29.54, while TRTN-PD trades at $22.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas TRTN-PD's P/E ratio is 2.83. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN-PD's ROE of +0.20%. Regarding short-term risk, CAI is more volatile compared to TRTN-PD. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TRTN-PD's competition here
CAI vs HTZ Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, HTZ has a market cap of 2.3B. Regarding current trading prices, CAI is priced at $29.54, while HTZ trades at $7.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas HTZ's P/E ratio is -0.73. In terms of profitability, CAI's ROE is +0.04%, compared to HTZ's ROE of -4.93%. Regarding short-term risk, CAI is less volatile compared to HTZ. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check HTZ's competition here
CAI vs TGH Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, TGH has a market cap of 2.1B. Regarding current trading prices, CAI is priced at $29.54, while TGH trades at $49.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas TGH's P/E ratio is 11.55. In terms of profitability, CAI's ROE is +0.04%, compared to TGH's ROE of +0.10%. Regarding short-term risk, CAI is more volatile compared to TGH. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TGH's competition here
CAI vs TRTN-PE Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, TRTN-PE has a market cap of 2B. Regarding current trading prices, CAI is priced at $29.54, while TRTN-PE trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas TRTN-PE's P/E ratio is 2.40. In terms of profitability, CAI's ROE is +0.04%, compared to TRTN-PE's ROE of +0.20%. Regarding short-term risk, CAI is more volatile compared to TRTN-PE. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TRTN-PE's competition here
CAI vs RCII Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, RCII has a market cap of 1.5B. Regarding current trading prices, CAI is priced at $29.54, while RCII trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas RCII's P/E ratio is 81.15. In terms of profitability, CAI's ROE is +0.04%, compared to RCII's ROE of +0.50%. Regarding short-term risk, CAI is less volatile compared to RCII. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check RCII's competition here
CAI vs CTOS Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, CTOS has a market cap of 1.3B. Regarding current trading prices, CAI is priced at $29.54, while CTOS trades at $5.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas CTOS's P/E ratio is -42.57. In terms of profitability, CAI's ROE is +0.04%, compared to CTOS's ROE of -0.02%. Regarding short-term risk, CAI is less volatile compared to CTOS. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check CTOS's competition here
CAI vs PRG Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, PRG has a market cap of 1.3B. Regarding current trading prices, CAI is priced at $29.54, while PRG trades at $32.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas PRG's P/E ratio is 6.46. In terms of profitability, CAI's ROE is +0.04%, compared to PRG's ROE of +0.33%. Regarding short-term risk, CAI is more volatile compared to PRG. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check PRG's competition here
CAI vs HTZWW Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, HTZWW has a market cap of 1.2B. Regarding current trading prices, CAI is priced at $29.54, while HTZWW trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas HTZWW's P/E ratio is 3.32. In terms of profitability, CAI's ROE is +0.04%, compared to HTZWW's ROE of -4.93%. Regarding short-term risk, CAI is less volatile compared to HTZWW. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check HTZWW's competition here
CAI vs TGH-PA Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, TGH-PA has a market cap of 1B. Regarding current trading prices, CAI is priced at $29.54, while TGH-PA trades at $25.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas TGH-PA's P/E ratio is 4.44. In terms of profitability, CAI's ROE is +0.04%, compared to TGH-PA's ROE of +0.10%. Regarding short-term risk, CAI is more volatile compared to TGH-PA. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TGH-PA's competition here
CAI vs TGH-PB Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, TGH-PB has a market cap of 1B. Regarding current trading prices, CAI is priced at $29.54, while TGH-PB trades at $25.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas TGH-PB's P/E ratio is 4.44. In terms of profitability, CAI's ROE is +0.04%, compared to TGH-PB's ROE of +0.10%. Regarding short-term risk, CAI is more volatile compared to TGH-PB. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check TGH-PB's competition here
CAI vs WLFC Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, WLFC has a market cap of 990.9M. Regarding current trading prices, CAI is priced at $29.54, while WLFC trades at $143.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas WLFC's P/E ratio is 9.87. In terms of profitability, CAI's ROE is +0.04%, compared to WLFC's ROE of +0.19%. Regarding short-term risk, CAI is more volatile compared to WLFC. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check WLFC's competition here
CAI vs ALTG-PA Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, ALTG-PA has a market cap of 841.7M. Regarding current trading prices, CAI is priced at $29.54, while ALTG-PA trades at $25.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas ALTG-PA's P/E ratio is -41.57. In terms of profitability, CAI's ROE is +0.04%, compared to ALTG-PA's ROE of -0.80%. Regarding short-term risk, CAI is more volatile compared to ALTG-PA. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check ALTG-PA's competition here
CAI vs VSTS Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, VSTS has a market cap of 840.8M. Regarding current trading prices, CAI is priced at $29.54, while VSTS trades at $6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas VSTS's P/E ratio is -33.58. In terms of profitability, CAI's ROE is +0.04%, compared to VSTS's ROE of -0.03%. Regarding short-term risk, CAI is more volatile compared to VSTS. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check VSTS's competition here
CAI vs AAN Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, AAN has a market cap of 318.3M. Regarding current trading prices, CAI is priced at $29.54, while AAN trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas AAN's P/E ratio is -7.26. In terms of profitability, CAI's ROE is +0.04%, compared to AAN's ROE of -0.06%. Regarding short-term risk, CAI is more volatile compared to AAN. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check AAN's competition here
CAI vs ALTG Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, ALTG has a market cap of 277.6M. Regarding current trading prices, CAI is priced at $29.54, while ALTG trades at $8.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas ALTG's P/E ratio is -3.75. In terms of profitability, CAI's ROE is +0.04%, compared to ALTG's ROE of -0.80%. Regarding short-term risk, CAI is less volatile compared to ALTG. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check ALTG's competition here
CAI vs MPU Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, MPU has a market cap of 108.4M. Regarding current trading prices, CAI is priced at $29.54, while MPU trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas MPU's P/E ratio is -9.48. In terms of profitability, CAI's ROE is +0.04%, compared to MPU's ROE of -0.71%. Regarding short-term risk, CAI is less volatile compared to MPU. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check MPU's competition here
CAI vs MTMT Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, MTMT has a market cap of 52.4M. Regarding current trading prices, CAI is priced at $29.54, while MTMT trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas MTMT's P/E ratio is N/A. In terms of profitability, CAI's ROE is +0.04%, compared to MTMT's ROE of -0.71%. Regarding short-term risk, CAI is less volatile compared to MTMT. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check MTMT's competition here
CAI vs FPAY Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, FPAY has a market cap of 27.7M. Regarding current trading prices, CAI is priced at $29.54, while FPAY trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas FPAY's P/E ratio is -6.45. In terms of profitability, CAI's ROE is +0.04%, compared to FPAY's ROE of -0.01%. Regarding short-term risk, CAI is less volatile compared to FPAY. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check FPAY's competition here
CAI vs MWG Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, MWG has a market cap of 9M. Regarding current trading prices, CAI is priced at $29.54, while MWG trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas MWG's P/E ratio is -2.99. In terms of profitability, CAI's ROE is +0.04%, compared to MWG's ROE of -0.14%. Regarding short-term risk, CAI is less volatile compared to MWG. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check MWG's competition here
CAI vs ZCAR Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, ZCAR has a market cap of 3.8M. Regarding current trading prices, CAI is priced at $29.54, while ZCAR trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas ZCAR's P/E ratio is -0.01. In terms of profitability, CAI's ROE is +0.04%, compared to ZCAR's ROE of +105.44%. Regarding short-term risk, CAI is less volatile compared to ZCAR. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check ZCAR's competition here
CAI vs BRDS Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, BRDS has a market cap of 1.3M. Regarding current trading prices, CAI is priced at $29.54, while BRDS trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas BRDS's P/E ratio is -0.01. In terms of profitability, CAI's ROE is +0.04%, compared to BRDS's ROE of -2.07%. Regarding short-term risk, CAI is less volatile compared to BRDS. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check BRDS's competition here
CAI vs HYRE Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, HYRE has a market cap of 486.8K. Regarding current trading prices, CAI is priced at $29.54, while HYRE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas HYRE's P/E ratio is -0.02. In terms of profitability, CAI's ROE is +0.04%, compared to HYRE's ROE of -46.89%. Regarding short-term risk, CAI is more volatile compared to HYRE. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check HYRE's competition here
CAI vs ZCARW Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, ZCARW has a market cap of 2.9K. Regarding current trading prices, CAI is priced at $29.54, while ZCARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas ZCARW's P/E ratio is N/A. In terms of profitability, CAI's ROE is +0.04%, compared to ZCARW's ROE of +105.44%. Regarding short-term risk, CAI is less volatile compared to ZCARW. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check ZCARW's competition here
CAI vs ACY Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, ACY has a market cap of 0. Regarding current trading prices, CAI is priced at $29.54, while ACY trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas ACY's P/E ratio is 4.30. In terms of profitability, CAI's ROE is +0.04%, compared to ACY's ROE of -0.71%. Regarding short-term risk, CAI is less volatile compared to ACY. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check ACY's competition here
CAI vs FTAI-PA Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, FTAI-PA has a market cap of 0. Regarding current trading prices, CAI is priced at $29.54, while FTAI-PA trades at $24.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas FTAI-PA's P/E ratio is -12.53. In terms of profitability, CAI's ROE is +0.04%, compared to FTAI-PA's ROE of +0.79%. Regarding short-term risk, CAI is more volatile compared to FTAI-PA. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAI-PA's competition here
CAI vs UHALB Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, UHALB has a market cap of 0. Regarding current trading prices, CAI is priced at $29.54, while UHALB trades at $53.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas UHALB's P/E ratio is 9.86. In terms of profitability, CAI's ROE is +0.04%, compared to UHALB's ROE of +0.05%. Regarding short-term risk, CAI is less volatile compared to UHALB. This indicates potentially lower risk in terms of short-term price fluctuations for CAI.Check UHALB's competition here
CAI vs FTAI-PC Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, FTAI-PC has a market cap of 0. Regarding current trading prices, CAI is priced at $29.54, while FTAI-PC trades at $25.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas FTAI-PC's P/E ratio is -13.00. In terms of profitability, CAI's ROE is +0.04%, compared to FTAI-PC's ROE of +0.79%. Regarding short-term risk, CAI is more volatile compared to FTAI-PC. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAI-PC's competition here
CAI vs FTAI-PB Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, FTAI-PB has a market cap of 0. Regarding current trading prices, CAI is priced at $29.54, while FTAI-PB trades at $24.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas FTAI-PB's P/E ratio is -12.26. In terms of profitability, CAI's ROE is +0.04%, compared to FTAI-PB's ROE of +0.79%. Regarding short-term risk, CAI is more volatile compared to FTAI-PB. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check FTAI-PB's competition here
CAI vs GFNCP Comparison July 2025
CAI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CAI stands at 8.2B. In comparison, GFNCP has a market cap of 0. Regarding current trading prices, CAI is priced at $29.54, while GFNCP trades at $101.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CAI currently has a P/E ratio of -11.49, whereas GFNCP's P/E ratio is 146.89. In terms of profitability, CAI's ROE is +0.04%, compared to GFNCP's ROE of +0.05%. Regarding short-term risk, CAI is more volatile compared to GFNCP. This indicates potentially higher risk in terms of short-term price fluctuations for CAI.Check GFNCP's competition here